The new antibiotic Zaynich, which combines cefepime with zidebactam, has completed clinical trials and will enter the market soon. The antibiotic Zaynich fights against carbapenem-resistant Gram-negative bacteria including E. coli, Klebsiella, Pseudomonas and Acinetobacter, which frequently cause hospital infections and show resistance to various medicationsThe new antibiotic Zaynich, which combines cefepime with zidebactam, has completed clinical trials and will enter the market soon. The antibiotic Zaynich fights against carbapenem-resistant Gram-negative bacteria including E. coli, Klebsiella, Pseudomonas and Acinetobacter, which frequently cause hospital infections and show resistance to various medications